Licensing Patent Patent Law 
SpicyIP
MARCH 11, 2025
Looking at different flexibilities under the Patent Act, like compulsory licensing, government use etc., Saha is an Associate Professor of Law, Faculty of Law, Banaras Hindu University. Image from here Right to Health and the Issue of Compulsory Licensing for Exorbitantly Priced Risdiplam By Prof.
Patently-O
MAY 15, 2024
as a major turning point in American patent and antitrust law. The Court’s 4-3 decision favored the patentee and allowed the patent owner to place restrictions on the use of its patented product even after sale. Just a few years later, the Supreme Court reversed course in Motion Picture Patents Co.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
SpicyIP
AUGUST 12, 2021
Ensuring Access to TB drugs: Is Compulsory License the Way? This is especially worrying since it is common knowledge that Indian patent law contains robust flexibilities to promote patient interest. To be clear, the life saving drugs in question- bedaquiline and delamanid, are scarce, expensive and patented till 2023.
SpicyIP
JUNE 22, 2022
The Belgian Health Care Knowledge Centre (KCE) recently released an interesting report titled ‘Compulsory licensing for expensive medicines’. Ordinarily, patentees voluntarily decide whether or not and on what conditions to grant licenses to third parties. Failing which, a compulsory license can be issued. Natco Pharma Ltd.
Patently-O
NOVEMBER 1, 2021
This Friday, November 5, the Iowa Innovation, Business & Law Center will be hosting a first-of-its-kind event (to the best of my knowledge at least): a panel discussion by patent law casebook authors about what makes their textbooks tick. Thomas, Cases and Materials on Patent Law (West Academic 2019).
Patently-O
JULY 21, 2022
Symbiont’s US Patent No. Holt was part of forming two additional companies, BJM and Matrix and Symbiont licensed the technology (including the patent) to those companies. The agreement included a number of provisions — primarily a license with royalties for feed sold using the process. by Dennis Crouch.
Patently-O
FEBRUARY 24, 2022
The Supreme Court has not yet granted writ of certiorari in any patent cases this term. And, absent an unusual shadow-docket patent case, it is now too late for any case to be granted and heard this term. Still, there are a number of important patent cases pending before the court. Neapco Holdings LLC, et al. , Patreon, Inc.,
Expert insights. Personalized for you.
105 
Let's personalize your content